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In this issue of Archives of Cardiovascular Diseases, an article from the Cardiology Depart-
ment of Purpan Hospital in Toulouse shows the signature of Professor Jacques Puel. When
vice-president of the French Society of Cardiology, Jacques created and led the Emergency
Working Group, one of whose objectives was to create synergy between emergency doc-
tors and cardiologists. Indeed, cardiology is increasingly present in the prehospital phase,
but also in emergency care. France has always been extremely creative in this ﬁeld, not
only with the ﬁrst observations of prehospital thrombolysis but also in randomized studies
such as CAPTIM [1].
There are many registries in cardiology, including CRUSADE, GRACE and FAST-MI, but
speciﬁc prehospitalization registries are rare. Jacques Puel was a major initiator of the
cooperative database, which required several years of data collection before any studies
were published.
The current study from the Midi-Pyrénées region sticks to the news presented by two
major studies, CARESS-in-AMI and FINESSE, both of which were published in 2008. The aim
of the ﬁrst was to investigate the optimal management of patients after thrombolytic
therapy [2]. Patients with ST-segment elevation myocardial infarction (STEMI) treated
by thrombolysis and abciximab were randomized to either immediate transfer for per-
cutaneous coronary intervention (PCI) or to standard medical therapy with transfer for
rescue angioplasty, if necessary. CARESS demonstrated that immediate transfer for PCI
improved outcome in high-risk patients with STEMI treated at a non-interventional centre
with half-dose reteplase and abciximab. The FINESSE study hypothesized that PCI preceded
by early treatment with abciximab plus half-dose reteplase (combination-facilitated PCI)
or with abciximab alone (abciximab-facilitated PCI) would improve outcomes in patients
with STEMI, compared with abciximab administered immediately before the procedure
 Determinants and prognostic impact of compliance with guidelines in reperfusion therapy for ST-segment elevation myocardial
infarction: Results from the ESTIM Midi-Pyrénées Area, Charpentier S, Sagnes-Raffy C, Cournot M, Cambou J.-P, Ducassé J.-L, Lauque D,
Puel J, for the ESTIM Midi-Pyrénées Investigators, doi:10.1016/j.acvd.2009.02.011.
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primary PCI) [3]. Neither facilitation of PCI with reteplase
lus abciximab nor facilitation with abciximab alone sig-
iﬁcantly improved the clinical outcome compared with
bciximab given at the time of PCI in patients with STEMI.
Jacques Puel’s work in this issue appears complemen-
ary to the OPTIMAL study, which he published in Heart
n 2008 [4]. The aim of the OPTIMAL study was to identify
redictors of early TIMI 3 ﬂow and patency of the infarct-
elated artery following prehospital thrombolysis in patients
ith STEMI, using data from a ‘‘real-world’’ population.
he group described for the ﬁrst time a ﬂowchart to triage
atients for emergency angiography. The ﬂowchart is a sim-
le tool based on clinical and electrocardiographic data.
The aim of the present study was to assess the impact
f guidelines on ‘‘real-world’’ practice and to compare
he results with those of large North American databases,
nd especially the American Heart Association ‘‘Get with
he Guidelines’’ database with 254 participating sites. In
he present study, prehospital guidelines were respected
n 61.1% of patients. The authors identiﬁed several factors
ssociated with non-compliance, the most common of which
as old age, but this ﬁnding has been consistent across
tudies and such analyses are always very difﬁcult. The sec-
nd factor was the impact of an atypical electrocardiogram
ECG), deﬁned as the presence of left bundle-branch block
r electrocardiographic abnormalities on the 12-lead ECG,
uggesting myocardial infarction in a right and posterior
ocation. Sandrine Charpentier pointed out that recom-
endations were implemented in 64.5% of cases with a
ypical ECG and in only 38% of patients with an atypical
CG. Improvements might therefore come not only from
hanges in training, but also thanks to new tools such as
[Y. Cottin, N. Danchin
elemedicine. The third ﬁnding of the present paper was
he role of time of symptom onset: compliance was better
hen the ﬁrst symptoms occurred during the daytime (odds
atio 1.43, 95% conﬁdence interval, 1.12—1.82).
On top of being a brilliant clinician and scientist, Jacques
uel was a remarkable orator and storyteller, and he often
poke of ‘‘Madame La Sécurité Sociale’’ or ‘‘Madame la
aute Autorité de Santé’’, who offers or requests. How-
ver, improvements in clinical practice will always result
rincipally from the work of clinicians and, in the present
ase, from developing synergy between specialties. Thus,
he work initiated by Jacques and the French Society of
ardiology should continue...
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